Literature DB >> 17440263

Kidney function and sarcopenia in the United States general population: NHANES III.

Robert N Foley1, Changchun Wang, Areef Ishani, Allan J Collins, Anne M Murray.   

Abstract

BACKGROUND/AIMS: It is not known whether sarcopenia is associated with levels of kidney function in community-dwelling adults.
METHODS: Subjects were adult Third National Health and Nutrition Examination Survey participants in whom bioimpedance was performed (n = 13,770). Class I sarcopenia was defined as a skeletal mass index of 1-2 standard deviations below and class II sarcopenia as < 2 standard deviations below young adult values.
RESULTS: A monotonic association existed between increasing sarcopenia prevalence and declining glomerular filtration rate: > or = 90 ml/min/1.73 m2, 22.8% class I, 3.8% class II sarcopenia; 60-89 ml/min/1.73 m2, 33.6% class I, 5.3% class II sarcopenia, and < 60 ml/min/1.73 m2, 50.7% class I, 9.4% class II sarcopenia (p < 0.0001). This association dissipated when adjustment was made for older age and more comorbidity. Multivariate associations (p < 0.05) of sarcopenia and chronic kidney disease included: older age; low income-to-poverty ratio; overweight; lack of exercise; low carbohydrate, fat and protein intake; hypercalcemia; low 25-hydroxy-vitamin D3; higher diastolic blood pressure, and insulin resistance.
CONCLUSION: Sarcopenia is common in community-dwelling adults with chronic kidney disease. Although causality cannot be assumed, several associations may be susceptible to intervention. 2007 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2007        PMID: 17440263     DOI: 10.1159/000101827

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  87 in total

1.  Misclassification of obesity in CKD: appearances are deceptive.

Authors:  Juan Jesús Carrero
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-12       Impact factor: 8.237

Review 2.  Muscle wasting in heart failure : The role of nutrition.

Authors:  Masakazu Saitoh; Marcelo Rodrigues Dos Santos; Stephan von Haehling
Journal:  Wien Klin Wochenschr       Date:  2016-10-19       Impact factor: 1.704

Review 3.  Muscle wasting in chronic kidney disease.

Authors:  Eduardo A Oliveira; Wai W Cheung; Kalodiah G Toma; Robert H Mak
Journal:  Pediatr Nephrol       Date:  2017-05-15       Impact factor: 3.714

4.  Early-stage chronic kidney disease, insulin resistance, and osteoporosis as risk factors of sarcopenia in aged population: the fourth Korea National Health and Nutrition Examination Survey (KNHANES IV), 2008-2009.

Authors:  J E Kim; Y-H Lee; J H Huh; D R Kang; Y Rhee; S-K Lim
Journal:  Osteoporos Int       Date:  2014-05-21       Impact factor: 4.507

5.  Glomerular filtration rate in the elderly and in the oldest old: correlation with frailty and mortality.

Authors:  Alberto Montesanto; Francesco De Rango; Maurizio Berardelli; Vincenzo Mari; Fabrizia Lattanzio; Giuseppe Passarino; Andrea Corsonello
Journal:  Age (Dordr)       Date:  2014-03-25

6.  The impact of the combination of kidney and physical function on cognitive decline over 2 years in older adults with pre-dialysis chronic kidney disease.

Authors:  Yuhei Otobe; Koji Hiraki; Chiharu Hotta; Kazuhiro P Izawa; Tsutomu Sakurada; Yugo Shibagaki
Journal:  Clin Exp Nephrol       Date:  2019-02-08       Impact factor: 2.801

7.  [Decline in renal function in old age : Part of physiological aging versus age-related disease].

Authors:  F Braun; P T Brinkkötter
Journal:  Z Gerontol Geriatr       Date:  2016-07-25       Impact factor: 1.281

8.  Evaluation of physical activity in sarcopenic conditions of kidney transplantation recipients.

Authors:  Masaaki Yanishi; Hiroyasu Tsukaguchi; Yutaka Kimura; Yuya Koito; Kenji Yoshida; Maiko Seo; Eri Jino; Motohiko Sugi; Hidefumi Kinoshita; Tadashi Matsuda
Journal:  Int Urol Nephrol       Date:  2017-07-19       Impact factor: 2.370

9.  Assessment of physical performance and body composition in male renal transplant patients.

Authors:  Andrea Petronio Rossi; Gianluigi Zaza; Marina Zanardo; Francesco Pedelini; Laura Dalla Verde; Chiara Caletti; Alessia D'Introno; Antonio Lupo; Mauro Zamboni
Journal:  J Nephrol       Date:  2018-03-17       Impact factor: 3.902

10.  Fibroblast growth factor 23 does not directly influence skeletal muscle cell proliferation and differentiation or ex vivo muscle contractility.

Authors:  Keith G Avin; Julian A Vallejo; Neal X Chen; Kun Wang; Chad D Touchberry; Marco Brotto; Sarah L Dallas; Sharon M Moe; Michael J Wacker
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-03-20       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.